Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-22

Clinical Trial Update: ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating novel ARV imaging for hair to elucidate non-adherence in HIV/AIDS patients; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV/AIDS | Phase 4 | Status: COMPLETED | Results posted: 2019-11-22